Credit Suisse: We Prefer Pfizer, Bristol Over Pharma Peers

By: via Benzinga
Credit Suisse reviewed its stances on major U.S. pharma names in a note this week, though the analysts came to the same conclusion ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.